Substituted pyrimidines for inhibiting Raf kinase activity

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9920048
SERIAL NO

15380515

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides methods of inhibiting Raf kinase activity in a patient, the method comprising administering to the patient a compound having formula I:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
XOMA (US) LLC2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Weirong Waltham, US 19 83
Cossrow, Jennifer San Mateo, US 7 110
Franklin, Lloyd Upton, US 7 57
Guan, Bing Needham, US 39 326
Jones, John Howard Framingham, US 15 117
Kumaravel, Gnanasambandam Westford, US 86 603
Lane, Benjamin Chelsea, US 18 78
Littke, Adam Boston, US 5 42
Lugovskoy, Alexey Woburn, US 30 247
Peng, Hairuo Needham, US 20 139
Powell, Noel Westford, US 15 200
Raimundo, Brian C San Francisco, US 8 128
Tanaka, Hiroko Foster City, US 88 899
Vessels, Jeffrey Marlborough, US 15 72
Wynn, Thomas Salem, US 5 61
Xin, Zhili Lexington, US 63 670

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 20, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 20, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00